149 related articles for article (PubMed ID: 34611289)
1. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.
Escala-Garcia M; Canisius S; Keeman R; Beesley J; Anton-Culver H; Arndt V; Augustinsson A; Becher H; Beckmann MW; Behrens S; Bermisheva M; Bojesen SE; Bolla MK; Brenner H; Canzian F; Castelao JE; Chang-Claude J; Chanock SJ; Couch FJ; Czene K; Daly MB; Dennis J; Devilee P; Dörk T; Dunning AM; Easton DF; Ekici AB; Eliassen AH; Fasching PA; Flyger H; Gago-Dominguez M; García-Closas M; García-Sáenz JA; Geisler J; Giles GG; Grip M; Gündert M; Hahnen E; Haiman CA; Håkansson N; Hall P; Hamann U; Hartikainen JM; Heemskerk-Gerritsen BAM; Hollestelle A; Hoppe R; Hopper JL; Hunter DJ; Jacot W; Jakubowska A; John EM; Jung AY; Kaaks R; Khusnutdinova E; Koppert LB; Kraft P; Kristensen VN; Kurian AW; Lambrechts D; Le Marchand L; Lindblom A; Luben RN; Lubiński J; Mannermaa A; Manoochehri M; Margolin S; Mavroudis D; Muranen TA; Nevanlinna H; Olshan AF; Olsson H; Park-Simon TW; Patel AV; Peterlongo P; Pharoah PDP; Punie K; Radice P; Rennert G; Rennert HS; Romero A; Roylance R; Rüdiger T; Ruebner M; Saloustros E; Sawyer EJ; Schmutzler RK; Schoemaker MJ; Scott C; Southey MC; Surowy H; Swerdlow AJ; Tamimi RM; Teras LR; Thomas E; Tomlinson I; Troester MA; Vachon CM; Wang Q; Winqvist R; Wolk A; Ziogas A; ; Michailidou K; Chenevix-Trench G; Bachelot T; Schmidt MK
Sci Rep; 2021 Oct; 11(1):19787. PubMed ID: 34611289
[TBL] [Abstract][Full Text] [Related]
2. Common germline polymorphisms associated with breast cancer-specific survival.
Pirie A; Guo Q; Kraft P; Canisius S; Eccles DM; Rahman N; Nevanlinna H; Chen C; Khan S; Tyrer J; Bolla MK; Wang Q; Dennis J; Michailidou K; Lush M; Dunning AM; Shah M; Czene K; Darabi H; Eriksson M; Lambrechts D; Weltens C; Leunen K; van Ongeval C; Nordestgaard BG; Nielsen SF; Flyger H; Rudolph A; Seibold P; Flesch-Janys D; Blomqvist C; Aittomäki K; Fagerholm R; Muranen TA; Olsen JE; Hallberg E; Vachon C; Knight JA; Glendon G; Mulligan AM; Broeks A; Cornelissen S; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Hopper JL; Tsimiklis H; Apicella C; Southey MC; Cross SS; Reed MW; Giles GG; Milne RL; McLean C; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Hooning MJ; Hollestelle A; Martens JW; van den Ouweland AM; Marme F; Schneeweiss A; Yang R; Burwinkel B; Figueroa J; Chanock SJ; Lissowska J; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Brenner H; Butterbach K; Holleczek B; Kataja V; Kosma VM; Hartikainen JM; Li J; Brand JS; Humphreys K; Devilee P; Tollenaar RA; Seynaeve C; Radice P; Peterlongo P; Manoukian S; Ficarazzi F; Beckmann MW; Hein A; Ekici AB; Balleine R; Phillips KA; ; Benitez J; Zamora MP; Perez JI; Menéndez P; Jakubowska A; Lubinski J; Gronwald J; Durda K; Hamann U; Kabisch M; Ulmer HU; Rüdiger T; Margolin S; Kristensen V; Nord S; ; Evans DG; Abraham J; Earl H; Poole CJ; Hiller L; Dunn JA; Bowden S; Yang R; Campa D; Diver WR; Gapstur SM; Gaudet MM; Hankinson S; Hoover RN; Hüsing A; Kaaks R; Machiela MJ; Willett W; Barrdahl M; Canzian F; Chin SF; Caldas C; Hunter DJ; Lindstrom S; Garcia-Closas M; Couch FJ; Chenevix-Trench G; Mannermaa A; Andrulis IL; Hall P; Chang-Claude J; Easton DF; Bojesen SE; Cox A; Fasching PA; Pharoah PD; Schmidt MK
Breast Cancer Res; 2015 Apr; 17(1):58. PubMed ID: 25897948
[TBL] [Abstract][Full Text] [Related]
3. Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival.
Azzato EM; Tyrer J; Fasching PA; Beckmann MW; Ekici AB; Schulz-Wendtland R; Bojesen SE; Nordestgaard BG; Flyger H; Milne RL; Arias JI; Menéndez P; Benítez J; Chang-Claude J; Hein R; Wang-Gohrke S; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Margolin S; Mannermaa A; Kosma VM; Kataja V; ; Beesley J; Chen X; Chenevix-Trench G; Couch FJ; Olson JE; Fredericksen ZS; Wang X; Giles GG; Severi G; Baglietto L; Southey MC; Devilee P; Tollenaar RA; Seynaeve C; García-Closas M; Lissowska J; Sherman ME; Bolton KL; Hall P; Czene K; Cox A; Brock IW; Elliott GC; Reed MW; Greenberg D; Anton-Culver H; Ziogas A; Humphreys M; Easton DF; Caporaso NE; Pharoah PD
J Natl Cancer Inst; 2010 May; 102(9):650-62. PubMed ID: 20308648
[TBL] [Abstract][Full Text] [Related]
4. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.
Morra A; Escala-Garcia M; Beesley J; Keeman R; Canisius S; Ahearn TU; Andrulis IL; Anton-Culver H; Arndt V; Auer PL; Augustinsson A; Beane Freeman LE; Becher H; Beckmann MW; Behrens S; Bojesen SE; Bolla MK; Brenner H; Brüning T; Buys SS; Caan B; Campa D; Canzian F; Castelao JE; Chang-Claude J; Chanock SJ; Cheng TD; Clarke CL; ; Colonna SV; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Dennis J; Dörk T; Dossus L; Dunning AM; Dwek M; Eccles DM; Ekici AB; Eliassen AH; Eriksson M; Evans DG; Fasching PA; Flyger H; Fritschi L; Gago-Dominguez M; García-Sáenz JA; Giles GG; Grip M; Guénel P; Gündert M; Hahnen E; Haiman CA; Håkansson N; Hall P; Hamann U; Hart SN; Hartikainen JM; Hartmann A; He W; Hooning MJ; Hoppe R; Hopper JL; Howell A; Hunter DJ; ; ; Jager A; Jakubowska A; Janni W; John EM; Jung AY; Kaaks R; Keupers M; Kitahara CM; Koutros S; Kraft P; Kristensen VN; Kurian AW; Lacey JV; Lambrechts D; Le Marchand L; Lindblom A; Linet M; Luben RN; Lubiński J; Lush M; Mannermaa A; Manoochehri M; Margolin S; Martens JWM; Martinez ME; Mavroudis D; Michailidou K; Milne RL; Mulligan AM; Muranen TA; Nevanlinna H; Newman WG; Nielsen SF; Nordestgaard BG; Olshan AF; Olsson H; Orr N; Park-Simon TW; Patel AV; Peissel B; Peterlongo P; Plaseska-Karanfilska D; Prajzendanc K; Prentice R; Presneau N; Rack B; Rennert G; Rennert HS; Rhenius V; Romero A; Roylance R; Ruebner M; Saloustros E; Sawyer EJ; Schmutzler RK; Schneeweiss A; Scott C; Shah M; Smichkoska S; Southey MC; Stone J; Surowy H; Swerdlow AJ; Tamimi RM; Tapper WJ; Teras LR; Terry MB; Tollenaar RAEM; Tomlinson I; Troester MA; Truong T; Vachon CM; Wang Q; Hurson AN; Winqvist R; Wolk A; Ziogas A; Brauch H; García-Closas M; Pharoah PDP; Easton DF; Chenevix-Trench G; Schmidt MK
Breast Cancer Res; 2021 Aug; 23(1):86. PubMed ID: 34407845
[TBL] [Abstract][Full Text] [Related]
5. Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.
Marouf C; Göhler S; Filho MI; Hajji O; Hemminki K; Nadifi S; Försti A
BMC Cancer; 2016 Feb; 16():165. PubMed ID: 26920143
[TBL] [Abstract][Full Text] [Related]
6. Presymptomatic Awareness of Germline Pathogenic BRCA Variants and Associated Outcomes in Women With Breast Cancer.
Hadar T; Mor P; Amit G; Lieberman S; Gekhtman D; Rabinovitch R; Levy-Lahad E
JAMA Oncol; 2020 Sep; 6(9):1460-1463. PubMed ID: 32644100
[TBL] [Abstract][Full Text] [Related]
7. Functional germline variants in driver genes of breast cancer.
Göhler S; Da Silva Filho MI; Johansson R; Enquist-Olsson K; Henriksson R; Hemminki K; Lenner P; Försti A
Cancer Causes Control; 2017 Apr; 28(4):259-271. PubMed ID: 28238063
[TBL] [Abstract][Full Text] [Related]
8. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.
Lei J; Rudolph A; Moysich KB; Rafiq S; Behrens S; Goode EL; Pharoah PP; Seibold P; Fasching PA; Andrulis IL; Kristensen VN; Couch FJ; Hamann U; Hooning MJ; Nevanlinna H; Eilber U; Bolla MK; Dennis J; Wang Q; Lindblom A; Mannermaa A; Lambrechts D; García-Closas M; Hall P; Chenevix-Trench G; Shah M; Luben R; Haeberle L; Ekici AB; Beckmann MW; Knight JA; Glendon G; Tchatchou S; Alnæs GI; Borresen-Dale AL; Nord S; Olson JE; Hallberg E; Vachon C; Torres D; Ulmer HU; Rüdiger T; Jager A; van Deurzen CH; Tilanus-Linthorst MM; Muranen TA; Aittomäki K; Blomqvist C; Margolin S; Kosma VM; Hartikainen JM; Kataja V; Hatse S; Wildiers H; Smeets A; Figueroa J; Chanock SJ; Lissowska J; Li J; Humphreys K; Phillips KA; ; Linn S; Cornelissen S; van den Broek SA; Kang D; Choi JY; Park SK; Yoo KY; Hsiung CN; Wu PE; Hou MF; Shen CY; Teo SH; Taib NA; Yip CH; Ho GF; Matsuo K; Ito H; Iwata H; Tajima K; Dunning AM; Benitez J; Czene K; Sucheston LE; Maishman T; Tapper WJ; Eccles D; Easton DF; Schmidt MK; Chang-Claude J
Breast Cancer Res; 2015 Feb; 17(1):18. PubMed ID: 25849327
[TBL] [Abstract][Full Text] [Related]
9. Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria.
Wang S; Pitt JJ; Zheng Y; Yoshimatsu TF; Gao G; Sanni A; Oluwasola O; Ajani M; Fitzgerald D; Odetunde A; Khramtsova G; Hurley I; Popoola A; Falusi A; Ogundiran T; Obafunwa J; Ojengbede O; Ibrahim N; Barretina J; White KP; Huo D; Olopade OI
Int J Cancer; 2019 Dec; 145(12):3321-3333. PubMed ID: 31173346
[TBL] [Abstract][Full Text] [Related]
10. Germline breast cancer susceptibility gene mutations and breast cancer outcomes.
Wang YA; Jian JW; Hung CF; Peng HP; Yang CF; Cheng HS; Yang AS
BMC Cancer; 2018 Mar; 18(1):315. PubMed ID: 29566657
[TBL] [Abstract][Full Text] [Related]
11. A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women.
Bensen JT; Graff M; Young KL; Sethupathy P; Parker J; Pecot CV; Currin K; Haddad SA; Ruiz-Narváez EA; Haiman CA; Hong CC; Sucheston-Campbell LE; Zhu Q; Liu S; Yao S; Bandera EV; Rosenberg L; Lunetta KL; Ambrosone CB; Palmer JR; Troester MA; Olshan AF
Breast Cancer Res; 2018 Jun; 20(1):45. PubMed ID: 29871690
[TBL] [Abstract][Full Text] [Related]
12. A Germline Mutation in the BRCA1 3’UTR Variant Predicts Susceptibility to Breast Cancer in a Saudi Arabian Population.
Mir R; Javid J; Al Balawi IA; Alkharsah KR; Hadi MA; Rahman MA; Hamoud E; Al Alawi Y; Al Zahrani ABM; Abu-Duhier FM
Asian Pac J Cancer Prev; 2018 Mar; 19(3):859-866. PubMed ID: 29582646
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia.
Yang XR; Devi BCR; Sung H; Guida J; Mucaki EJ; Xiao Y; Best A; Garland L; Xie Y; Hu N; Rodriguez-Herrera M; Wang C; Jones K; Luo W; Hicks B; Tang TS; Moitra K; Rogan PK; Dean M
Breast Cancer Res Treat; 2017 Oct; 165(3):687-697. PubMed ID: 28664506
[TBL] [Abstract][Full Text] [Related]
14. Association between HER2 germline mutation A270S and prognosis in patients with primary breast cancer.
Si P; Xu Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
Cancer Biomark; 2018; 23(2):165-171. PubMed ID: 30175972
[TBL] [Abstract][Full Text] [Related]
15. Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups.
van den Broek AJ; Broeks A; Horlings HM; Canisius SV; Braaf LM; Langerød A; Van't Veer LJ; Schmidt MK
Breast Cancer Res Treat; 2011 Nov; 130(2):599-608. PubMed ID: 21667122
[TBL] [Abstract][Full Text] [Related]
16. Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer.
Le Rhun E; Bertrand N; Dumont A; Tresch E; Le Deley MC; Mailliez A; Preusser M; Weller M; Revillion F; Bonneterre J
Eur J Cancer; 2017 Dec; 87():189-198. PubMed ID: 29103666
[TBL] [Abstract][Full Text] [Related]
17. Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer.
Udler M; Maia AT; Cebrian A; Brown C; Greenberg D; Shah M; Caldas C; Dunning A; Easton D; Ponder B; Pharoah P
J Clin Oncol; 2007 Jul; 25(21):3015-23. PubMed ID: 17634480
[TBL] [Abstract][Full Text] [Related]
18. Association of germline microRNA SNPs in pre-miRNA flanking region and breast cancer risk and survival: the Carolina Breast Cancer Study.
Bensen JT; Tse CK; Nyante SJ; Barnholtz-Sloan JS; Cole SR; Millikan RC
Cancer Causes Control; 2013 Jun; 24(6):1099-109. PubMed ID: 23526039
[TBL] [Abstract][Full Text] [Related]
19. Functional Screenings Identify Regulatory Variants Associated with Breast Cancer Susceptibility.
Ren N; Li Y; Xiong Y; Li P; Ren Y; Huang Q
Curr Issues Mol Biol; 2021 Oct; 43(3):1756-1777. PubMed ID: 34889888
[TBL] [Abstract][Full Text] [Related]
20. Role of Genetic Variation in ABC Transporters in Breast Cancer Prognosis and Therapy Response.
Hlaváč V; Václavíková R; Brynychová V; Koževnikovová R; Kopečková K; Vrána D; Gatěk J; Souček P
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33334016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
